-+ 0.00%
-+ 0.00%
-+ 0.00%

Blau Farmacêutica Approves Investment of Up to US$ 2 Million in PLEX Subsidiary

PUBT·10/30/2026 20:12:17
Listen to the news
Blau Farmacêutica Approves Investment of Up to US$ 2 Million in PLEX Subsidiary
  • Blau Farmacêutica’s board met on October 28, 2026, unanimously backing investment in its US subsidiary.
  • The investment of up to US$ 2 million in wholly owned PLEX – Plasma Experts will support a future capital increase.
  • Funds may be remitted by the end of fiscal 2026; the executive board was authorized to implement the investment.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Blau Farmaceutica SA published the original content used to generate this news brief on October 30, 2026, and is solely responsible for the information contained therein.